The Role of Adjuvant Therapy with Bisphosphonates in Cancer

作者: Alexander H G Paterson

DOI: 10.2165/00024669-200403010-00003

关键词:

摘要: An understanding of the pathophysiology bone metastases requires a knowledge normal and abnormal remodeling. This is helpful in mechanisms action active agents such as bisphosphonates. When malignant cells infiltrate spaces, balance formation resorption disrupted: remodeling turnover become abnormal. The consequent ‘vicious cycle’ plays central role progressive destruction progression metastases. cycle breast cancer beginning to be understood involves secretion by substances parathyroid hormone related protein (PTHrP) which leads an increase focal generalized resulting release breakdown products transforming growth factor beta turn stimulates further cells. Study intricacies this has thrown some light on potential opportunities for therapy However, physiological pain are poorly understood. Clinical aspects cancer, prostate myeloma, together with what known about their individual discussed review. Biochemical markers now available study early research suggests that skeletal events patients disease well treatment these may correlate levels serum urine turnover.

参考文章(94)
SJ Holmes, RW Whitehouse, ST Clark, DC Crowther, JE Adams, SM Shalet, Reduced bone mineral density in men following chemotherapy for Hodgkin's disease. British Journal of Cancer. ,vol. 70, pp. 371- 375 ,(1994) , 10.1038/BJC.1994.308
R.E Coleman, S Houston, O.P Purohit, R.D Rubens, A Kandra, J Ford, A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer. European Journal of Cancer. ,vol. 34, pp. 820- 824 ,(1998) , 10.1016/S0959-8049(97)10155-1
L. Joseph Melton, Elizabeth A. Chrischilles, Cyrus Cooper, Ann W. Lane, B. Lawrence Riggs, Perspective how many women have osteoporosis? Journal of Bone and Mineral Research. ,vol. 7, pp. 1005- 1010 ,(2009) , 10.1002/JBMR.5650070902
PD Delmas, R Eastell, P Garnero, MJ Seibel, J Stepan, Committee of Scientific Advisors of the International Osteoporosis Foundation, The Use of Biochemical Markers of Bone Turnover in Osteoporosis Osteoporosis International. ,vol. 11, pp. 2- 17 ,(2000) , 10.1007/S001980070002
Toshiyuki Yoneda, Akira Sasaki, Gregory R. Mundy, Osteolytic bone metastasis in breast cancer Breast Cancer Research and Treatment. ,vol. 32, pp. 73- 84 ,(1994) , 10.1007/BF00666208
ELLEN SIMPSON, JANE HARROD, GABRIEL EILON, JOHN W. JACOBS, GREGORY R. MUNDY, Identification of a messenger ribonucleic acid fraction in human prostatic cancer cells coding for a novel osteoblast-stimulating factor. Endocrinology. ,vol. 117, pp. 1615- 1620 ,(1985) , 10.1210/ENDO-117-4-1615
Claire M Shipman, Michael J Rogers, Jane F Apperley, R Graham G Russell, Peter I Croucher, None, Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity. British Journal of Haematology. ,vol. 98, pp. 665- 672 ,(1997) , 10.1046/J.1365-2141.1997.2713086.X
J.A. Kanis, R.C. Percival, A.J.P. Yates, G.H. Urwin, N.A.T. Hamdy, EFFECTS OF DIPHOSPHONATES IN HYPERCALCAEMIA DUE TO NEOPLASIA The Lancet. ,vol. 327, pp. 615- 616 ,(1986) , 10.1016/S0140-6736(86)92834-5